Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist delivered through subcutaneous injection into fatty tissue, typically in the abdominal area. Proper injection site selection and rotation prevent lipodystrophy (fat pad changes) and ensure consistent medication absorption. PlexusDx compounded semaglutide injections start at $149 per month and come with guidance on correct injection technique for optimal results.

Approved Stomach Injection Locations for Semaglutide

The FDA-approved injection zones for semaglutide include the lower abdomen, upper arm, and thigh. For abdominal injections specifically, the area between the ribs and hip bones offers the most fatty tissue depth and fewest nerve endings. This zone minimizes discomfort while allowing the medication to absorb steadily into the bloodstream over several hours.

Within the abdomen, aim for the soft tissue at least two inches away from the belly button in any direction. Avoid injecting directly over bones, bruised areas, tender spots, or scars. Many patients find the lower belly—below the natural waistline—easier to access and less psychologically distressing than upper abdominal sites. The key is choosing an area with visible subcutaneous fat that feels soft when pinched.

Rotation Strategy Prevents Lipodystrophy and Improves Absorption

Rotating injection sites weekly or with each injection reduces the risk of lipohypertrophy (thickened fatty tissue) and lipoatrophy (sunken areas), both of which can slow medication absorption. Many GLP-1 patients inject once weekly, making a simple rotation pattern essential. A practical approach is to divide the abdomen into four quadrants—upper-right, upper-left, lower-right, lower-left—and use each quadrant once per month before cycling back.

Spacing injections at least one inch apart prevents compound irritation and maintains healthy tissue integrity. If you notice lumps, dimples, or hardened areas at previous injection sites, skip that region entirely until the tissue normalizes. PlexusDx patients can track their rotation schedule in a calendar or phone app to ensure consistency. This simple habit maximizes semaglutide efficacy and reduces injection-related complications.

Correct Injection Depth and Technique Matter for Efficacy

Semaglutide must be injected into subcutaneous tissue—the layer of fat beneath the skin but above muscle. Insert the needle at a 45- to 90-degree angle, depending on abdominal fat thickness, until you feel slight resistance, then inject slowly. A needle that goes too deep risks hitting muscle or organs; one that stays too shallow sits in the dermis and may cause irritation or poor absorption.

Before each injection, clean the site with an alcohol swab and wait 30 seconds for it to dry. Pinching the skin creates a thicker fat fold and steadies the injection area. After injecting, withdraw the needle slowly and do not rub the injection site—light pressure for a few seconds is sufficient. These technique details ensure consistent medication delivery and reduce bruising, bleeding, and infection risk.

PlexusDx Compounded Semaglutide and Personalized Injection Support

PlexusDx compounds semaglutide through licensed 503A pharmacies, matching the quality and purity of brand-name formulations while lowering out-of-pocket costs. Compounded semaglutide injections start at $149 per month with no membership fees or insurance requirement. Every PlexusDx patient receives detailed injection instruction materials covering site selection, needle handling, and storage guidelines.

For patients seeking deeper personalization, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month) to identify genetic variants affecting GLP-1 receptor function and metabolic response. Understanding your genetic predisposition to GLP-1 pathways helps optimize dose timing and injection frequency. All PlexusDx medications are HSA/FSA eligible, making treatment accessible across all 50 states.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide anywhere on my body besides the abdomen?

Yes. Semaglutide can be injected into the thigh or upper arm, though abdominal sites offer the largest usable area and simplest rotation options. PlexusDx provides injection guidance for all approved zones to help you find the most comfortable location for your weekly dosing schedule.

What happens if I inject semaglutide into muscle instead of fat?

Injecting into muscle can cause localized pain, inflammation, and unpredictable absorption rates. Proper subcutaneous placement ensures steady medication release and consistent weight loss results. Always pinch the skin to identify the fat layer and inject at the correct depth using the technique outlined in PlexusDx guidance materials.

How much does PlexusDx compounded semaglutide cost monthly?

PlexusDx semaglutide injections start at $149 per month across all commitment tiers—your dose may need to go up, but your price won't. No membership fees, insurance requirements, or hidden charges. Treatment is HSA/FSA eligible and available in all 50 states.

Is bruising or swelling normal after semaglutide injection?

Minor bruising is common, especially early in treatment. Swelling beyond the injection site or bruising that spreads may indicate a blood vessel was nicked or depth was incorrect. Rotate sites weekly, allow injection sites to heal fully, and contact your healthcare provider if swelling persists longer than two days.

Does the Precision Peptide Genetic Test help with injection site decisions?

The Precision Peptide Genetic Test maps your GLP-1R genetic variants (such as rs6923761) and identifies how your body processes semaglutide at the molecular level. While it doesn't change injection site selection, it helps optimize dose response and timing. This $99 add-on allows PlexusDx to personalize your entire weight loss protocol based on your peptide-pathway genetics.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves